Update on Procalcitonin Measurements

키워드

참고문헌 (105)

1. Kumar A, "Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock", Crit Care Med, 34, pp.1589~1596 (2006)
2. Dellinger RP, "Surviving sepsis campaign: international guideline for management of severe sepsis and septic shock: 2012", Crit Care Med, 41, pp.580~637 (2013)
3. Bouadma L, "Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised control trial", Lancet, 375, pp.463~474 (2010)
4. Stolz D, "Procalcitonin for reduced antibiotic exposure in ventilator associated pneumonia: a randomised stury", Eur Respir J, 34, pp.1364~1375 (2009)
5. Hochreiter M, "Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy", Anaesthesist, 57, pp.571~577 (2008)
6. Schroeder S, "Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study", Langenbecks Arch Surg, 394, pp.221~226 (2009)
7. Qu R, "Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial", Saudi Med J, 33, pp.382~387 (2012)
8. Briel M, "Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care", Arch Intern Med, 168, pp.2000~2007 (2008)
9. Stolz D, "Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy", Chest, 131, pp.9~19 (2007)
10. Höffken G, "Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen (akute Bronchitis, akute Exazerbation einer chronischen Bronchitis, Influenza und andere respiratorische Virusinfektionen) sowie ambulant erworbener Pneumonie", Pneumonologie, 63, pp.1~68 (2009)
11. Reinhart K, "Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI))", Ger Med Sci, 8, pp.1~86 (2010)
12. Assicot M, "High serum procalcitonin concentrations in patients with sepsis and infection", Lancet, 341, pp.515~518 (1993)
13. Linscheid P, "Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and macrophage-activated adipocytes", Crit Care Med, 32, pp.1715~1721 (2004)
14. Meisner M, "Induction of procalcitonin and proinflammatory cytokines in an anheptic baboon endotoxin shock model", Shock, 19, pp.187~190 (2003)
15. Wiedermann FJ, "Migration of human monocytes in response to procalcitonin", Crit Care Med, 30, pp.1112~1117 (2002)
16. Hoffmann G, "In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin", Crit Care Med, 29, pp.112~116 (2001)
17. Hoffmann G, "Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells", Crit Care Med, 30, pp.2091~2095 (2002)
18. Müller B, "Procalcitonin: how a hormone became a marker and mediator of sepsis", Swiss Med Wkly, 131, pp.595~602 (2001)
19. Wrenger S, "Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV)", FEBS Lett, 466, pp.155~159 (2000)
20. Castelli GP, "Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction", Crit Care, 8, pp.234~242 (2004)
21. Ugarte H, "Procalcitonin used as a marker of infection in the intensive care unit", Crit Care Med, 27, pp.498~504 (1999)
22. Uzzan B, "Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis", Crit Care Med, 34, pp.1996~2003 (2006)
23. Meisner M, "Postoperative plasma concentrations of procalcitonin after different types of surgery", Intensive Care Med, 24, pp.680~684 (1998)
24. Clec’h C, "Diagnostic and prognostic value of procalcitonin in patients with septic shock", Crit Care Med, 32, pp.1166~1169 (2004)
25. van Langevelde P, "Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality", Clin Infect Dis, 31, pp.1343~1348 (2000)
26. Oberhoffer M, "Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro", J Lab Clin Med, 134, pp.49~55 (1999)
27. Jekarl DW, "Procalcitonin as a diagnostic Marker and IL-6 as a prognostic marker for sepsis", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 75, pp.342~347 (2013), ELSEVIER SCIENCE INC
28. Pfister R, "Procalcitonin for diagnosis of bacterial pneumonia in critically illpatients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis", Crit Care, 18, pp.44~ (2014)
29. Gendrel D, "Measurement of procalcitonin levels in children with bacterial and viral meningitis", Clin Infect Dis, 24, pp.1240~1242 (1997)
30. Moulin F, "Procalcitonin in children admitted to hospital with community acquired pneumonia", Arch Dis Child, 84, pp.332~336 (2001)
31. Mathew B, "The use of procalcitonin as a marker of sepsis in children", J Clin Diagn Res, 7, pp.305~307 (2013)
32. Festic E, "The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage", Neurocrit Care, 2 (2014)
33. Peters RP, "The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients", Clin Microbiol Infect, 12, pp.1207~1213 (2006)
34. Liaudat S, "Usefulness of procalcitonin serum level for the diagnosis of bacteremia", Eur J Clin Microbiol Infect Dis, 20, pp.524~527 (2001)
35. vanNieuwkoop C, "Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study", Crit Care, 14, pp.206~ (2010)
36. Georgopoulou AP, "Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis", J Crit Care, 26, pp.331~ (2011)
37. Kylänpää-Bäck ML, "Procalcitonin strip test in the early detection of severe acute pancreatitis", Br J Surg, 88, pp.222~227 (2001)
38. Rau B, "Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study", Ann Surg, 245, pp.745~754 (2007)
39. Kylänpää-Bäck ML, "Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis", Crit Care Med, 29, pp.63~69 (2001)
40. Magrini L, "Procalcitonin variations after emergency department admission are highly predictive of hospital mortality in patients with acute infectious disease", Eur Rev Med Pharmacol Sci, 17(1), pp.113~142 (2013)
41. Seligman R, "Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia", Crit Care, 10, pp.125~ (2006)
42. Hatherill M, "Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock", Crit Care Med, 28, pp.2591~2594 (2000)
43. Friederichs J, "Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections", Am J Surg, 206, pp.368~373 (2013)
44. Meisner M, "The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function", Eur J Anaesthesiol, 18, pp.79~87 (2001)
45. Wojciechowicz KH, "Conservative treatment of acute appendicitis: an overview", Int Marit Health, 62, pp.265~272 (2010)
46. Ansaloni L, "Surgery versus conservative antibiotic treatment in acute appen dicitiis: a systematic review and meta-analysis of randomized controlled trials", Dig Surg, 28, pp.210~221 (2011)
47. Chandel V, "Procalcitonin as the biomarker of inflammation in diagnosis of appendicitis in pediatric patients and prevention of unneccesary appendectomies", Indian J Surg, 73, pp.136~141 (2011)
48. Wu JY, "Diagnostic role of procalcitonin in patients with suspected appendicitis", Word J Surg, 36, pp.1774~1779 (2012)
49. Kafetzis DA, "Procalcitonin as a predictor of severe appendicitis in children", Eur J Clin Microbiol Infect Dis, 24, pp.484~487 (2005)
50. Yu CW, "Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute appendicitis", Br J Surg, 100, pp.322~329 (2013)
51. Schuetz P, "Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections", JAMA, 302, pp.1059~1066 (2009)
52. Nobre V, "Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial", Am J Respir Crit Care Med, 177, pp.498~505 (2008)
53. Gibot S, "Procalcitonin in intensive care units: the PRORATA trial", Lancet, 375, pp.1605~1606 (2010)
54. Tarnow-Mordi W, "Procalcitonin in intensive care units: the PRORATA trial", Lancet, 375, pp.1605~ (2010)
55. Schuetz P, "Procalcitonin to initiate or discontinue antibiotiics in acute respiratory tract infections", Evid Based Child Health, 8, pp.1297~1371 (2013)
56. Wilke MH, "The use of standardized PCT-algorithm reduces costs in intensive care in septic patients-a DRG-based simulation model", Eur J Med Res, 16, pp.543~548 (2011)
57. Albrich WC, "Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life”: an international, multicenter poststudy survey (ProREAL)", Arch Intern Med, 172, pp.715~722 (2012)
58. Kook JL, "Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital", Infect Control Hosp Epidemiol, 33, pp.424~426 (2012)
59. Assink-de Jong E, "Stop Antibiotics on guidance of Procalcitonin study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--caluculated sample size: 1816 patients", BMC Infect Dis, 13, pp.178~ (2013)
60. Deliberato RO, "Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting", Diagn Microbiol Infect Dis, 76, pp.266~271 (2013)
61. Dusemund F, "Influence of procalcitonin on decision to start antibiotic treatment in patients with lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance", Eur J Clin Microbiol Infect Dis, 32, pp.51~60 (2013)
62. Annane D, "Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial", BMJ Open, 3, pp.002186~ (2013)
63. Liew YX, "Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies", Eur J Clin Microbiol Infect Dis, 31, pp.3041~3046 (2012)
64. Ding J, "Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis", Int J Med Sci, 10, pp.903~907 (2013)
65. Christ-Crain M, "Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster- randomised, single-blinded intervention trial", Lancet, 363, pp.600~607 (2004)
66. Christ-Crain M, "Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial", Am J Respir Crit Care Med, 174, pp.84~93 (2006)
67. Hohn A, "Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock", BMC Infect Dis, 13, pp.158~ (2013)
68. Meisner M, "Postoperative plasma concentration of procalcitonin and C-reactive protein in patients undergoing cardiac and thoracic surgery with and without cardiopulmonary bypass", Cardiovasc Eng, 3, pp.174~178 (1998)
69. Syvänen J, "Normal behaviour of plasma procalcitonin in adolescents undergoing surgery for scoliosis", Scand J Surg, 103, pp.60~65 (2014)
70. Wanner GA, "Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients", Crit Care Med, 28, pp.950~957 (2000)
71. Meisner M, "Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients", Crit Care, 10, pp.1~ (2006)
72. vonHeimburg D, "Procalcitonin -- a sepsis parameter in severe burn injuries", Burns, 24, pp.745~750 (1998)
73. Lavrentieva A, "Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis?", Burns, 33, pp.189~194 (2007)
74. Ulrich D, "Plasma endotoxin, procalcitonin, C-reaktives protein, andorgan functions in patients with major burns", Handchir Mikrochir Plast Chir, 33, pp.262~266 (2001)
75. Carsin H, "Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFα and endotoxin levels early after thermal injury", Burns, 23, pp.218~224 (1997)
76. de Werra I, "Cytokines, nitrite", nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia, 1997, pp.25, 607~613
77. Brunkhorst FM, "Procalcitonin-immunoreactivity in patients with cardiogenic shock- does bacterial inflammation influence the prognosis?", Eur Heart J, 17(2), pp.67~72 (1996)
78. Geppert A, "Usefulness of procalcitonin for diagnosing complicating sepsis in patients with car diogenic shock", Intensive Care Med, 29, pp.1384~1389 (2003)
79. Nylén ES, "Effect of classic heatstroke on serum procalcitonin", Crit Care Med, 25, pp.1362~1365 (1997)
80. Hausfater P, "Is procalcitonin a marker of criticall illness in heatstroke?", Intensive Care Med, 34, pp.1377~1383 (2008)
81. Sabat R, "Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies", Intensive Care Med, 27, pp.987~991 (2001)
82. Abramowicz D, "Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients", Transplantation, 47, pp.606~608 (1989)
83. Rau B, "The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis", Intensive Care Med, 26(2), pp.159~164 (2000)
84. Scirè CA, "Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases", ClinExpRheumatol, 24, pp.123~128 (2006)
85. Korczowski B, "Serum procalcitonin concentration in children with liver disease", Pediatr Infect Dis J, 25, pp.268~269 (2006)
86. Delèvaux I, "Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes ?", Ann Rheum Dis, 62, pp.337~340 (2003)
87. Scirè CA, "Plasma procalcitonin in rheumatic diseases", Reumatismo, 55, pp.113~118 (2003)
88. Kádár J, "Adult-onset Still´s disease", Best Pract Res Clin Rheumatol, 18, pp.663~676 (2004)
89. Moosig F, "Elevated procalcitonin levels in active Wegener’s granulomatosis", J Rheumatol, 25, pp.1531~1533 (1998)
90. Eberhard OK, "Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus", systemic antineutrophil cytoplasmatic antibody-associated vasculitis) and invasive bacterial infection, 1997, pp.40, 1250~1256
91. Dahaba AA, "Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis", Intensive Care Med, 29, pp.579~583 (2003)
92. Steinbach G, "Procalcitonin in patients with acute and chronic renal insufficiency", Wien Klin Wochenschr, 116, pp.849~853 (2004)
93. Meisner M, "Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients", Shock, 15, pp.171~175 (2001)
94. Schmidt M, "Procalcitonin in patients undergoing chronic hemodialysis", Nephron, 84, pp.187~188 (2000)
95. Elefsiniotis IS, "Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease", Eur J Gastroenterol Hepatol, 18, pp.525~530 (2006)
96. Attar BM, "Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites", World J Gastroenterol, 20, pp.2374~2382 (2014)
97. Fries M, "Procalcitonin serum levels after ouf-of-hospital cardiac arrest", Resuscitation, 59, pp.105~109 (2003)
98. Oppert M, "Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation", Resuscitation, 53, pp.167~170 (2002)
99. Chiesa C, "Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates", Clin Infect Dis, 26, pp.664~672 (1998)
100. Turner D, "Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram", Arch Dis Child Fetal Neonatal Ed, 91, pp.283~286 (2006)
101. Stocker M, "Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial", Neonatology, 97, pp.165~174 (2010)
102. Lencot S, "A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm", Eur J Clin Microbiol Infect Dis (2014)
103. Jimeno A, "Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia", Cancer, 100, pp.2462~2469 (2004)
104. Bihan H, "Calcitonin precursor levels in human medullary thyroid carcinoma", Thyroid, 13, pp.819~822 (2003)
105. Morgenthaler NG, "Detection of Procalcitonin(PCT)in healthy controls and patients with local infection by a sensitive ILMA", Clin Lab, 48, pp.263~270 (2002)

관련 논문AI추천